Arong, Caridad R.
HRN: 03-37-42 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/03/2023
CEFTRIAXONE 1G (VIAL)
12/03/2023
12/10/2023
IV
2g
OD
UTI
Waiting Final Action
Indication: Empiric Type of Infection: Urinary TractEye, Ear, Nose, Throat, & Mouth Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes